Aclidinium
- MDIAclidiniumBretaris Genuair
Mechanism of Action
- Inhibits muscarinic (M3) receptors, leading to bronchial smooth muscle relaxation and bronchodilation through reduction in acetylcholine-mediated vagal tone.
Clinical Use
Indications
- Maintenance therapy for COPD
- Adverse Effects
- Dry mouth
- Headache